VWA5A Polyclonal antibody

VWA5A Polyclonal Antibody for IHC, ELISA
Cat No. 26175-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

IHC, ELISA

BCSC1, Breast cancer suppressor candidate 1, von Willebrand factor A domain containing 5A

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IHC detected inmouse liver tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Immunohistochemistry (IHC)IHC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

26175-1-AP targets VWA5A in IHC, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen VWA5A fusion protein Ag22010 Predict reactive species
Full Name von Willebrand factor A domain containing 5A
Calculated Molecular Weight 786 aa, 86 kDa
GenBank Accession NumberBC001234
Gene Symbol VWA5A
Gene ID (NCBI) 4013
RRIDAB_3669526
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDO00534
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

VWA5A, also known as BCSC1 or LOH11CR2A, may function as a tumor suppressor in tumorigenesis. The lower expression of VWA5A may serve as a potential biomarker for metastasis-prone breast cancers (PMID: 38291227).

Protocols

Product Specific Protocols
IHC protocol for VWA5A antibody 26175-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...